How is nandrolone decanoate dosed, and how many mL is a dose?

50 mg of Nandrolone Decanoate (Deca-Durabolin) at 100 mg/mL is 0.5 mL, the 50 mark on a U-100 syringe.

Every vial at a glance. Pick a cell to draw it on the syringe.

Each row is a concentration; units are the dose over the concentration, times 100, on a U-100 syringe.
ConcentrationDraw per dose
50 mg/mL50 mg/mL: 25 mg is 0.5 mL, the 50 mark, 50 mg is 1 mL, the 100 mark, 100 mg is over 1 mL, 200 mg is over 1 mL
100 mg/mL100 mg/mL: 25 mg is 0.25 mL, the 25 mark, 50 mg is 0.5 mL, the 50 mark, 100 mg is 1 mL, the 100 mark, 200 mg is over 1 mL
200 mg/mL200 mg/mL: 25 mg is 0.125 mL, the 12.5 mark, 50 mg is 0.25 mL, the 25 mark, 100 mg is 0.5 mL, the 50 mark, 200 mg is 1 mL, the 100 mark

Jump to a vial 50 mg/mL 100 mg/mL 200 mg/mL

The Irish text gives adults a usual initial dose of 25 to 50 mg, with 3 weeks between doses; for anemia of renal disease, the US label gives 50 to 100 mg per week for women and 100 to 200 mg per week for men.12

Strengths, mL and syringe marks

The US label from Watson Laboratories, literature revised March 2006, describes a sesame oil solution holding 100 mg or 200 mg of nandrolone decanoate per mL.2 The 100 mg per mL pack is a 2 mL multiple dose vial and the 200 mg per mL pack a 1 mL single dose vial.2 The Irish authorisation lists 50 mg/ml in a 1 ml glass syringe, and Health Canada shows its 50 mg/mL record as cancelled since 1996.13 Every product listed is a ready-made oil, with no powder or water step.1

50 mg of Nandrolone Decanoate (Deca-Durabolin) at 100 mg/mL is 0.5 mL, the 50 mark on a U-100 syringe.

What the labels give for adults and children

The Irish text gives adults an initial dose of 25 to 50 mg, with 3 weeks between doses, and says 50 mg once every 3 weeks may be used in acute renal failure, osteoporosis or mammary carcinoma.1 For anemia of renal disease it gives 50 to 100 mg per week for women and 100 to 200 mg per week for men.2

For anemia of renal disease in children aged 2 to 13, the US label gives an average dose of 25 to 50 mg every 3 to 4 weeks.2 The Irish text varies children's dosage with the state of the child, up to 0.5 mg/kg body weight once every 3 weeks.1 The Irish text also says that, since the product contains benzyl alcohol, it is not for children younger than 3 years.1

What trials used, arm by arm

Each trial below is a research regimen, not a label dose.

TrialDose and schedulePeopleLength
Frisoli 2005, osteoporosisEvery 3 weeks: 50 mg or placebo, with 500 mg calcium daily for all4Sixty-five osteoporotic women older than 70 (Thirty-two nandrolone, 33 placebo)2-year treatment
Gold 2006, HIV-positive menEvery 2 weeks, intramuscularly: nandrolone 150 mg, testosterone 250 mg or placebo5Three hundred and three men12 weeks
Johansen 1999, dialysisOnce a week, intramuscularly: 100 mg or placebo6Twenty-nine patients on dialysis (14 nandrolone, 15 placebo)6 months
Mulligan 2005, HIV-infected womenEvery other week, intramuscularly: 100 mg or placebo738 women12 weeks blinded, then 12 open-label
Crawford 2003, men on long-term glucocorticoidsEvery fortnight, intramuscularly: nandrolone 200 mg, testosterone 200 mg mixed esters or placebo851 men12 months
Creutzberg 2003, COPDDeep intramuscular, days 1, 15, 29 and 43: 50 mg in 1 mL of arachis oil or 1 mL of arachis oil placebo, with a standardized pulmonary rehabilitation program for all963 menDays 1 to 43
Johansen 2006, hemodialysisWeekly: 100 mg for women, 200 mg for men, or placebo, in a 2 x 2 trial with resistance exercise training1079 patients12 weeks
Hartgens 2001, bodybuildersWeekly, intramuscularly: 200 mg or placebo1116 subjectsEight weeks

Joint pain and bodybuilding

Neither label gives a dose for joint pain or for bodybuilding use, and the US label says the drug has not been shown to be safe and effective for the enhancement of athletic performance.2 In a 2020 pilot by Tatem and colleagues, hypogonadal men on testosterone injections started nandrolone decanoate at half their testosterone cypionate dose; forty-eight eligible patients completed the initial survey, and of the 18 men who responded to follow-up, 13 reported marked improvements in joint pain.12 The pilot's review describes a 1987 controlled trial by Bird et al. in postmenopausal women with rheumatoid arthritis, in which intramuscular nandrolone decanoate 50 mg every 3 weeks for 2 years found no significant difference in joint or bone pain compared with the control arm.12 The same review describes Darracott et al., with improved symptoms after 6 weeks in patellofemoral pain syndrome, and Hohmann et al., in 10 patients after total knee arthroplasty, whose authors did not report the pain subscore.12

Storage

The US label says to store at 20 to 25 C, protect from light and store in the carton until the contents are used.2 The Irish text gives a shelf life of 3 years as packaged, says store below 25 C, do not refrigerate and keep the syringe in the outer carton to protect from light, and says the product must be used immediately after opening.1 The US label gives no after-puncture storage statement for its multiple dose vial.

Frequently asked questions

Can nandrolone decanoate be injected subcutaneously?

The US label gives deep intramuscular injection only, into the gluteal muscle preferably, the Irish text gives deep intramuscular injection, and the Health Canada record lists the route as intramuscular.213 A 2014 pharmacokinetic study by Singh and colleagues gave healthy male volunteers a single subcutaneous 100 mg dose and reported that the subcutaneous injections were well tolerated.13 No label or trial lists a subcutaneous schedule.

What warnings come with the labelled dose?

The Irish text says pregnancy is a contraindication because the drug may produce virilisation of offspring.1

References

  1. HPRA. License. assets.hpra.ie
  2. Watson Laboratories (DailyMed). NANDROLONE DECANOATE INJECTION USP FOR INTRAMUSCULAR USE C-III Rx only. 2007. dailymed.nlm.nih.gov
  3. Health Canada. Product information. health-products.canada.ca
  4. PubMed. The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial. 2005. pubmed.ncbi.nlm.nih.gov
  5. PubMed. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. 2006. pubmed.ncbi.nlm.nih.gov
  6. PubMed. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. 1999. pubmed.ncbi.nlm.nih.gov
  7. PubMed. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. 2005. pubmed.ncbi.nlm.nih.gov
  8. PubMed. Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. 2003. pubmed.ncbi.nlm.nih.gov
  9. PubMed. A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. 2003. pubmed.ncbi.nlm.nih.gov
  10. PubMed. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial. 2006. pubmed.ncbi.nlm.nih.gov
  11. PubMed. Body composition and anthropometry in bodybuilders: regional changes due to nandrolone decanoate administration. 2001. pubmed.ncbi.nlm.nih.gov
  12. PMC. Nandrolone decanoate relieves joint pain in hypogonadal men: a novel prospective pilot study and review of the literature. 2020. pmc.ncbi.nlm.nih.gov
  13. PubMed. Pharmacokinetic-pharmacodynamic study of subcutaneous injection of depot nandrolone decanoate using dried blood spots sampling coupled with ultrapressure liquid chromatography tandem mass spectrometry assays. 2014. pubmed.ncbi.nlm.nih.gov